Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancer

Cancer Immunology Immunotherapy

Volumn 46, Issue 1, 1998, Pages 1-6

  Hiramatsu, K ^a   Yanagawa, H ^a   Haku, T ^a   Sone, S ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cytotoxicity; Interleukin 12; Lung cancer; Malignant pleural effusion

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; KILLER CELL; LUNG CANCER; MONONUCLEAR CELL; PLEURA EFFUSION; PRIORITY JOURNAL;

CELL SEPARATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MONOCYTES; MONOCYTES, ACTIVATED KILLER; PLEURAL EFFUSION, MALIGNANT; TUMOR CELLS, CULTURED;

EID: 0031914286     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050452     Document Type: Article

References (30)

1. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A (1994) Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84:2261
2. Bigda J, Mysliwska J, Dziadziuszko R, Bigda J, Mysliwski A, Hellmann A (1993) Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia. Leuk Lymphoma 10:121
3. Brunda MJ, Luistro L, Warner RR, Wright RB, Hubbard B, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223
4. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G (1991) Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173:869
5. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G (1993) Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cell. Eur J Immunol 23:1829
6. Chen YM, Yang WK, Whang-Peng J, Kuo BI, Perng RP (1996) Elevation of interleukin-10 levels in malignant pleural effusion. Chest 110:433
7. Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T (1997) In vitro interleukin 12 activation of peripheral blood CD3+CD56+ and CD3+CD56-γδ T cells from glioblastoma patients. Clin Cancer Res 3:633
8. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127
9. Haku T, Sone S, Nabioullin R, Ogura T (1995) Human alveolar macrophages augment natural killer cell activity stimulatory factor (interleukin 12) inducible killer activity from autologous blood lymphocytes. Jpn J Cancer Res 86:81
10. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM (1997) In vivo production and function of IL-12 homodimers. J Immunol 158:4381
11. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K (1996) Local production of the p40 subunit of the interleukin 12 suppresses T-helper I-mediated immune responses and prevent allogeneic myoblast rejection. Proc Natl Acad Sci USA 93:9085
12. Kobayashi M, Fitz L, Ryan M, Hewick PM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827
13. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YE, Hakimi J (1995) Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116
14. Manetti R, Parronchi P, Giudizi M, Piccini M, Maggi E, Trinchieri G. Romagnani S (1993) Natural killer cell stimulatory factor (NKSF-IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing T cells. J Exp Med 177:1199
15. Nabioullin R, Sone S, Mizuno K, Yano S, Nishioka Y, Haku T, Ogura T (1994) IL-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J Leukoc Biol 55:437
16. + T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin 12). Jpn J Cancer Res 85:853
17. Nastala CL, Edington HD, Mckinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153:1697
18. Naume B, Gately M, Espevvik T (1992) A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, IL-7-induced effects on immunogenetically purified CD56+ NK cells. J Immunol 148:2429
19. Nii A, Sone S, Utsugi T, Yanagawa H, Ogura T (1988) Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes depending on their functional state. Int J Cancer 41:33
20. Soiffer RJ, Robertson MJ, Murray C, Cockran K, Ritz J (1993) Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82:2790
21. Sone S, Ogura T (1994) Local interleukin-2 therapy for cancer, and its effector induction mechanisms. Oncology 51:170
22. Sone S, Utsugi T, Nii A, Ogura T (1987) Effects of human alveolar macrophages on the induction of lymphokine (IL-2)-activated killer cells. J Immunol 139:29
23. Sone S, Kunishige E, Fawsy F, Yanagawa H, Nii A, Maeda K, Atagi S, Heike Y, Nishioka Y, Mizuno K, Ogura T (1991) Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients. Jpn J Cancer Res 82:716
24. Sone S, Yanagawa H, Nishioka Y, Orino E, Bhaskaran G, Nii A, Mizuno K, Heike Y, Ogushi F, Ogura T (1992) Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producting tumor necrosis factor-α and interleukin-1. Eur Respir J 5:174
25. Sone S, Yanagawa H, Nii A, Ogura T (1993) Induction of interleukin 2-activated killer effector activity and its regulatory mechanism. Gann Monogr Cancer Res 40:81
26. Stern AS, Podlaski FJ, Hulmes JD, Pan ECE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808
27. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87:581
28. Waal Malefyt R de, Haanen J, Spits H, Roncarolo MG, Velde A te, Figdor C, Johnson K, Kastelein R, Yssel H, Vries JE de (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174:915
29. Yanagawa H, Sone S, Nii A, Fukuta K, Nakanishi M, Maeda K, Honda M, Ogura T (1989) Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusion. Jpn J Cancer Res 80:1220
30. Yanagawa H, Sone S, Sugihara K, Tanaka K, Ogura T (1991) Interleukin-4 down-regulates interleukin-6 production by alveolar macrophages at protein and mRNA levels. Microbiol Immunol 35:879